Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography

Biomedical Chromatography

Volumn 19, Issue 1, 2005, Pages 32-35

  Jang, Dong Jin ^a   Park, Jeong Sook ^a   Ko, Hye Ran ^a   Jee, Jun Pil ^a   Kim, Jin Ki ^a   Kim, Sung Tae ^a   Kim, Chong Kook ^a  

^a Seoul National University   (South Korea)

Author keywords

High performance liquid chromatography (HPLC); Niflumic acid; Prodrug; Talniflumate

Indexed keywords

PLASMA (HUMAN);

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN PLASMAS; INDOMETHACIN; METHANOL-WATER; NIFLUMIC ACID; PRODRUGS; SIMULTANEOUS DETERMINATIONS; TALNIFLUMATE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACETIC ACID; INDOMETACIN; METHANOL; NIFLUMIC ACID; PRODRUG; TALNIFLUMATE; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ELUTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LINEAR SYSTEM; MALE; MONITORING; NORMAL HUMAN; PH; PLOTS AND CURVES; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; TIME; ULTRAVIOLET RADIATION;

EID: 14544276357     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.412     Document Type: Article

References (12)

1. Battista HJ, Wehinger G and Henn R. Separation and identification of non-steroidal antirheumatic drugs containing a free carboxyl function using high-performance liquid chromatography. Journal of Chromatography 1985; 345: 77.
2. Boissier JR, Tillement JP and Larousse C, Metabolisms of niflumic acid in man. Therapie 1971; 26: 211.
3. Cuechot C and Nicolle P. Purity assay of niflumic acid by reversed-phase high-perfomance liquid chromatography. Journal of Chromatography 1984; 303: 440.
4. Egorova A, Beltyukova S, Teslyuk O and Karpinchik V. Application of f-f luminescence of terbium ion for determination of non-steroidal anti-inflammatory drug niflumic acid. Journal of Pharmaceutical and Biomedical Analysis 2001; 24: 1081.
5. Gowik P, Julicher B and Uhlig S. Multi-residue method for non-steroidal anti-inflammatory drugs in plasma using high-performance liquid chromatography photodiode-array detection. Journal of Chromatography B 1998; 716: 221.
6. Huin G, Bree F and Tillement JP. Quantitative determination of niflumic acid and its β-morpholinoethyl ester in human plasma by gas-liquid chromatography. Journal of Chromatography 1981; 223 351.
7. Kim HJ, Han YH, Chung SJ, Lee MH and Shim CG. Pharmacokinetics of talniflumate, a prodrug of niflumic acid, following oral administration to man. Archives of Pharmaceutical Research 1996; 19: 297.
8. Lapicque F, Netter P, Bannwarth B, Trechot P, Gillet P, Lambert H and Royer RJ. Identification and simultaneous determination of non-steroidal anti-inflammatory drugs using high-performance liquid chromatography. Journal of Chromatography 1989; 496: 310.
9. Los M, Boned JE and Piccininali C. New esters of substituted anilinonicotinic and phenylanthranilic acids. Pharmacological Science 1981; 36: 372.
10. Martindale, 32nd edn. The Pharmaceutical Press: London, 1999; 63.
11. Shumacher A, Geissler HE and Mutschler E. Fluorometric determination of plasma niflumic aicd by direct estimation of thin layer chromatograms. Journal of Chromatography 1979; 162: 489.
12. Takacs-Novak K, Avdeef A, Box KJ, Podanyi B and Szasz G. Determination of protonation macro- and microconstants and octanol/water partition coefficient of the anti-inflammatory drug niflumic acid. Journal of Pharmaceutical and Biomedical Analysis 1994; 12: 1369.